Skip to main content

MoneyWorks4Me

Strides Pharma Science informs about press release

06 Sep 2024 Evaluate
Strides Pharma Science has informed that it attached Press Release issued by the Company titled: ‘Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..